131 related articles for article (PubMed ID: 7834165)
1. Endogenous digoxin-like substance in liver failure.
Lucena MI; Andrade RJ; Fraile JM; Alcantara R; Gonzalez-Correa JA; De La Cuesta FS
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):567-9. PubMed ID: 7834165
[TBL] [Abstract][Full Text] [Related]
2. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
[TBL] [Abstract][Full Text] [Related]
3. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
Lackner TE; Lau BW; Parvin C; Valdes R
Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
[TBL] [Abstract][Full Text] [Related]
4. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
Marzullo C; Bourderont D; Dorr R
Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
[TBL] [Abstract][Full Text] [Related]
5. Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations.
Wu SL; Li W; Wells A; Dasgupta A
Am J Clin Pathol; 2001 Apr; 115(4):600-4. PubMed ID: 11293909
[TBL] [Abstract][Full Text] [Related]
6. Endogenous glycosides in critically ill patients.
Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone interference with digoxin radioimmunoassay in cirrhotic patients.
DiPiro JT; Cote JR; DiPiro CR; Bustrack JA
Am J Hosp Pharm; 1980 Nov; 37(11):1518-21. PubMed ID: 7211855
[TBL] [Abstract][Full Text] [Related]
8. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
9. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
Li J; Wu Z; Xu J; Zhou Y; Chu X
Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
[TBL] [Abstract][Full Text] [Related]
10. Digoxin-like immunoreactive substance in postmortem blood of infants and children.
Spiehler VR; Fischer WR; Richards RG
J Forensic Sci; 1985 Jan; 30(1):86-91. PubMed ID: 3981124
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
[TBL] [Abstract][Full Text] [Related]
12. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
13. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
Li JH; Wu ZG; Xu JQ; Zhou Y
Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
[TBL] [Abstract][Full Text] [Related]
14. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients.
Avendaño C; Alvarez JS; Sacristan JA; Adin J; Alsar MJ
Ther Drug Monit; 1991 Nov; 13(6):523-7. PubMed ID: 1771650
[TBL] [Abstract][Full Text] [Related]
15. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
16. [False values of blood digoxin in patients with acute and chronic liver disease. Role of canrenoate potassium and comparison of radioimmunologic and immunoenzymatic methods].
Nardoni A; di Piazza V; Moretti V; Copetti R; Trinco G; Geatti O
Clin Ter; 1988 May; 125(4):287-90. PubMed ID: 2974364
[No Abstract] [Full Text] [Related]
17. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
Hu KQ; Yu AS; Tiyyagura L; Redeker AG; Reynolds TB
Am J Gastroenterol; 2001 May; 96(5):1581-6. PubMed ID: 11374703
[TBL] [Abstract][Full Text] [Related]
18. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
19. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests.
Collazos J; Mendarte U; De Miguel J
Gastroenterol Clin Biol; 1993; 17(2):79-82. PubMed ID: 8500713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
